We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$811M
AUM Growth
+$1.5M
Cap. Flow
-$70.5M
Cap. Flow %
-8.7%
Top 10 Hldgs %
33.67%
Holding
353
New
14
Increased
39
Reduced
103
Closed
14

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$7.85M
2
CVS icon
CVS Health
CVS
+$3.51M
3
A icon
Agilent Technologies
A
+$1.36M
4
WFC icon
Wells Fargo
WFC
+$1.17M
5
GLW icon
Corning
GLW
+$1.1M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$11.1M
2
AAPL icon
Apple
AAPL
+$5.32M
3
AMZN icon
Amazon
AMZN
+$4.99M
4
CMI icon
Cummins
CMI
+$4.89M
5
MSFT icon
Microsoft
MSFT
+$4.66M

Sector Composition

Rank Sector Weight
1 Technology 25.05%
2 Financials 16.09%
3 Healthcare 14.98%
4 Consumer Discretionary 12.22%
5 Industrials 11.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBIN icon
101
Fortune Brands Innovations
FBIN
$5.91B
$1.89M 0.23%
42,264
-7,128
-14% -$335K
CGNX icon
102
Cognex
CGNX
$9.62B
$1.84M 0.23%
33,002
-5,382
-14% -$276K
APD icon
103
Air Products & Chemicals
APD
$65.5B
$1.76M 0.22%
10,496
-1,588
-13% -$259K
T icon
104
AT&T
T
$167B
$844K 0.1%
33,305
+21,267
+177% +$521K
QTWO icon
105
Q2 Holdings
QTWO
$3.84B
$822K 0.1%
13,572
– –
FICO icon
106
Fair Isaac
FICO
$32.4B
$766K 0.09%
3,353
– –
SRPT icon
107
Sarepta Therapeutics
SRPT
$1.65B
$710K 0.09%
4,393
– –
TDY icon
108
Teledyne Technologies
TDY
$29.4B
$663K 0.08%
2,687
– –
TXRH icon
109
Texas Roadhouse
TXRH
$13.7B
$644K 0.08%
9,290
+1,503
+19% +$102K
EHC icon
110
Encompass Health
EHC
$11.3B
$641K 0.08%
10,301
– –
INXN
111
DELISTED
Interxion Holding N.V.
INXN
$627K 0.08%
9,316
– –
BCPC
112
Balchem Corp
BCPC
$5.26B
$622K 0.08%
5,551
– –
COHR icon
113
Coherent
COHR
$43.9B
$586K 0.07%
12,387
– –
MRCY icon
114
Mercury Systems
MRCY
$5.54B
$582K 0.07%
10,519
– –
HQY icon
115
HealthEquity
HQY
$8.67B
$580K 0.07%
6,139
– –
INTC icon
116
Intel
INTC
$423B
$543K 0.07%
11,478
– –
PAYC icon
117
Paycom
PAYC
$7.98B
$535K 0.07%
3,440
– –
ROKU icon
118
Roku
ROKU
$21.5B
$531K 0.07%
+7,270
New +$416K
ICUI icon
119
ICU Medical
ICUI
$4.14B
$527K 0.07%
1,865
– –
ABBV icon
120
AbbVie
ABBV
$470B
$525K 0.06%
5,555
– –
CSCO icon
121
Cisco
CSCO
$451B
$519K 0.06%
10,663
– –
CHE icon
122
Chemed
CHE
$7.09B
$508K 0.06%
1,589
– –
FIVN icon
123
FIVE9
FIVN
$2.11B
$508K 0.06%
11,627
+2,190
+23% +$90.3K
LOXO
124
DELISTED
Loxo Oncology, Inc
LOXO
$508K 0.06%
2,975
– –
KWR icon
125
Quaker Houghton
KWR
$2.54B
$504K 0.06%
2,493
– –
3 4
5
6 7

Similar funds

ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return
AG
Ascent Group Virginia Beach, Virginia $2.89B AUM 19.6% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
CWM
Calamos Wealth Management Naperville, Illinois $2.91B AUM 25.59% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
PFM
Potomac Fund Management Miami, Florida $2.88B AUM 15.75% 1-Year Est. Return
DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $2.88B AUM 18.53% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return

Silvant Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Silvant Capital Management held 353 positions worth $811M, up 0.19% from $809M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Silvant Capital Management withdrew a net $70.5M in Q3 2018, closing 14 positions and reducing 103 holdings. Its most notable exit was Lam Research, an estimated $2.73M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Silvant Capital Management opened a new position in Roku worth $531K.

  • Silvant Capital Management's largest Q3 2018 buy was Roku: 7,270 shares worth $531K.
  • Silvant Capital Management added most to Mastercard in Q3 2018, an estimated $7.85M increase.
  • Silvant Capital Management's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $11.1M.
  • Silvant Capital Management fully exited Lam Research in Q3 2018, selling an estimated $2.73M.
  • Silvant Capital Management's ten largest holdings make up 34% of its $811M portfolio in Q3 2018.
  • Silvant Capital Management opened 14 new positions and closed 14 in Q3 2018.
  • Silvant Capital Management's portfolio value rose 0.19% quarter-over-quarter to $811M.

Based on Silvant Capital Management's 13F filing for Q3 2018, filed 7 Nov 2018.